Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,000.00
-20.00 (-0.66%)
Nov 13, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 184.62 billion as of November 12, 2026. It is the 22,808th most valuable company in the world and the 844th biggest in South Korea. Its market cap has decreased by 50.30% in one year.
Market Cap
184.62B
Enterprise Value
242.82B
Revenue
99.15B
Global Rank
Country Rank
#844 South Korea
PE Ratio
19.20
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 184.62B, a decrease of -59.10%. That is a compound annual growth rate of -15.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 184.62B | -40.36% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 310.45B |
| ToolGen | 288.28B |
| Curexo | 274.79B |
| Value Added Technology | 250.29B |
| Vieworks | 237.05B |
| JETEMA, | 229.69B |
| Boditech Med | 201.88B |
| MSBIO | 158.32B |